Skip to content
News and updates

Category: Biomedical Research

Trump Administration Releases FY27 Research Priorities Document

Posted on

On Thursday, the Trump Administration released its Fiscal Year (FY) 2027 Administration Research and Development Budget Priorities and Cross-Cutting Actions Document. The document, signed by OMB Director Russ Vought and OSTP Director Michael Krastios, outlines the administration’s research priorities, describing its mission to align the government’s “role in the S&T enterprise to once again drive R&D that is bold, mission-driven, and unapologetically in service of the American people.”

Vought and Krastios list 5 top administration priorities in the coming fiscal year. The priorities are to:

  1. Ensure Unrivaled American Leadership in Critical and Emergin Technologies
  2. Unleash American Energy Dominance and Explore New Frontiers
  3. Strengthen American Security
  4. Strengthen and Safeguard American Health and Biotechnology
  5. Assure America’s Continued Space Dominance

The memorandum also describes the administration’s intent to undertake a number of crosscutting actions to “usher in the Golden Age of American Innovation.” These include:

  1. Implementing and Supporting Gold Standard Science
  2. Building the S&T Workforce of the Future
  3. Expanding and Making Accessible World-Class Research Infrastructure
  4. Revitalizing and Strengthening America’s S&T Ecosystem
  5. Focusing on High-Value Research Efforts.

Specifics regarding each priority can be found in the document linked above.

 

 

 

 

NIH Pauses Grant Cancellations

Posted on

In an internal NIH memo circulated on Tuesday, Michelle Bulls, who helps oversee the agency’s external funding arm, directed agency staff not to cancel any additional research projects. Bulls instructed staff that, “effective immediately, please do not terminate any additional grant projects.” The memo marks a retreat by the agency, which has slashed funding for medical research and terminated hundreds of awards since the beginning of the Trump administration.

The memo comes in the wake of two important court decisions regarding cuts to federal research funding. A federal judge in Massachusetts ruled last week that some of the administration’s grant cancellations were “void and illegal,” and accused the government of racial discrimination and prejudice against LGBTQ individuals. Additionally, a federal judge in California temporarily blocked the canceling of grants to the University of California on Monday, ruling that the grant terminations violated the First Amendment. The administration is considering appeals to both decisions.

In the meantime, N.I.H. officials said they were continuing to categorize medical research grants based on whether they included topics disfavored by the Trump administration, even if they were not terminating those grants.

 

 

Trump Signs Executive Orders on Nuclear Energy & Federal Research

Posted on

Last week, President Trump signed two Executive Orders on nuclear energy and Gold Standard Science.

The Reinvigorating the Nuclear Industrial Base order seeks to expedite and promote the production and operation of nuclear energy in America by streamlining regulations, allowing reactor construction on federal lands, and requiring the Nuclear Regulatory Commission to issue licensing decisions within 18 months. The orders also promote uranium mining and enrichment to strengthen the domestic nuclear fuel supply.

Meanwhile, the Restoring Gold Standard Science Executive Order mandates that federally funded research adhere to stricter principles of transparency and reproducibility standards. The Executive Order cites falling public trust in scientific research as justification for the new instructions, which include new definitions for numerous terms and strict enforcement guidelines. The new procedures are set to take place within 30 days.

 

Bhattacharya Confirmed as NIH Director

Posted on

On March 25, the Senate voted 53-47, along party lines, to confirm Jayanta Bhattacharya, M.D., PhD to be Director of the National Institutes of Health (NIH). Following the vote, Senator Bill Cassidy, M.D. (R-La.), Chair of the Senate Health, Education, Labor, and Pensions Committee, issued a statement saying “The NIH needs a leader that will restore Americans’ trust in public health institutions and find unbiased solutions to Americans’ most challenging health problems,” and “Dr. Bhattacharya is ready to take on this responsibility and implement President Trump’s vision to Make America Healthy Again.”

NIH & FDA Director Nominees Advance

Posted on

Dr. Jay Bhattacharya, President Trump’s pick to lead the National Institutes of Health, was advanced by the Senate Health, Education, Labor and Pensions Committee. The Committee voted 12-11 along party lines, with all Republicans voting in favor and all Democrats voting against.

Similarly, Trump’s pick to head the Food and Drug Administration, Marty Makary, was advanced out of the committee by a 14-9 vote, with Democrats Maggie Hassan of New Hampshire and John Hickenlooper of Colorado joining all Republicans in voting to advance.

Bhattacharya and Makary will now appear for a confirmation vote before the entire Senate, with the Republican majority all but ensuring that they will be confirmed.